biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	0E22C709-9AF5-4D06-B165-8C82A3EC4B07
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EH-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EH-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EH-01A
biospecimen__bio__biospecimen_barcode_bottom	0108434075
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A1EH.951E7AFB-F380-4FA8-B213-CB766A60FF5B.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A131
biospecimen__bio__plate_row	D
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	4.27
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	26.70
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EH
biospecimen__shared__patient_id	A1EH
clinical__ablation__ablation_performed_indicator	YES
clinical__ablation__ablation_type	Radiofrequency Ablation
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A1EH-A45785
clinical__ablation__bcr_ablation_uuid	5BD6AA35-352F-459E-BFCB-FDD1929F1153
clinical__ablation__days_to_ablation_performed	126
clinical__ablation__embolization_performed_indicator	NO
clinical__ablation__treatment_cycles_count	1
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	4E47D93C-9B66-4DD3-8ACA-998D5F13BBA1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.7
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	94340
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	9.5
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	13.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.4
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	23
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EH-F42567
clinical__clin_shared__bcr_followup_uuid	343DEC20-1DC4-4B49-802D-86E849463D82
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	24
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Partial Response
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	212
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	120
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Lung
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__rx__bcr_drug_barcode	TCGA-DD-A1EH-D45786
clinical__rx__bcr_drug_uuid	7F848383-13AF-41E4-890D-56CDCC89F3F2
clinical__rx__days_to_drug_therapy_end	721
clinical__rx__days_to_drug_therapy_start	553
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	0559ff1c-6aee-491f-9b58-747732a10755
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EH-01A-11R-A131-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	064009db-7d3e-4f77-aa09-f291ff9cd742,05ae1ce4-6362-4671-bff0-410865c6df72,c0d7d1bb-a74d-4e79-bbd4-3cd8a468ac3e
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.93
gdc__analytes__analyte_id	fe852573-9716-46b6-8604-004eb884d543
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	cab5b264-abab-4bdb-816e-9d2c0ac30629
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-30T18:48:03.298666-05:00,2016-05-30T18:48:03.515320-05:00,2016-05-30T18:48:03.704239-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	4afbc555-5b5f-52ef-8a2f-2e72d0458722
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1985
gdc__diagnoses__age_at_diagnosis	8499
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-8499.0
gdc__diagnoses__days_to_last_follow_up	1495.0
gdc__diagnoses__diagnosis_id	b59e5416-fbab-5072-a1d5-78d15f9178c2
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	21.847008520333322
gdc__exposures__exposure_id	496093aa-a923-5b8d-a3fe-b4d074ffc05c
gdc__exposures__height	179.0
gdc__exposures__weight	70.0
gdc__file_id	95eb0a63-5b05-40f7-b7e0-d62354096d87,0ca81768-4036-41e8-974a-947ba746c761,aaa4746e-6d0f-4d33-8128-1c90a0258431
gdc__file_name	6f3dfcf1-9cd9-4c1e-91a2-58efd909dcb7.htseq.counts.gz,6f3dfcf1-9cd9-4c1e-91a2-58efd909dcb7.FPKM-UQ.txt.gz,6f3dfcf1-9cd9-4c1e-91a2-58efd909dcb7.FPKM.txt.gz
gdc__file_size	249679,500136,498317
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	703e38c071a947ade89073a5ede86ee4,33ddb99efdb93c3f9a780dc62556c714,2b7ad3781cf376c2172a89495519290a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	b4123697-c651-4225-b73f-a73d347547af
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	933
gdc__samples__initial_weight	220.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	951E7AFB-F380-4FA8-B213-CB766A60FF5B
gdc__samples__sample_id	44c98b82-adcb-4597-a9db-83e7d2a0e2f9
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	5.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	a8728f9e-ae4c-4c71-aabc-c055f5115669
gdc__submitter_id	6f3dfcf1-9cd9-4c1e-91a2-58efd909dcb7_count,6f3dfcf1-9cd9-4c1e-91a2-58efd909dcb7_uqfpkm,6f3dfcf1-9cd9-4c1e-91a2-58efd909dcb7_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	111ffd20-041c-55e6-aa1c-f91c980a3dde
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:04:49.658+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/0559ff1c-6aee-491f-9b58-747732a10755-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/0559ff1c-6aee-491f-9b58-747732a10755-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5077742
manually_curated__local_md5	f3ca3efeeb12042793a471c0e79e193c
manually_curated__opengdc_download_date	2018-10-15T16:19:17.000718+02:00
manually_curated__opengdc_file_md5	359db9a526035c31413add329723695a
manually_curated__opengdc_file_size	1631472
manually_curated__opengdc_id	0559ff1c-6aee-491f-9b58-747732a10755-geq
manually_curated__origin_file_size	5077742
manually_curated__origin_last_modified_date	Mon Oct 15 16:35:00 CEST 2018
manually_curated__origin_md5	f3ca3efeeb12042793a471c0e79e193c
manually_curated__tissue_status	tumoral
num	60483
